Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 9, 2016
Previous Article Next Article

Synthesis and anticancer properties of 3-methylene-4-(2-oxoalkyl)-3,4-dihydrocoumarins

Author affiliations

Abstract

A simple and general strategy for the synthesis of 3-methylene-4-(2-oxoalkyl)-3,4-dihydrocoumarins has been developed. The elaborated synthetic protocol includes 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD)- or Cs2CO3-promoted conjugate addition of enolizable ketones to 3-(diethoxyphosphoryl)coumarins followed by Horner–Wadsworth–Emmons reaction of the resulting 3-diethoxyphosphoryl-4-(2-oxoalkyl)-3,4-dihydrocoumarins with formaldehyde. For prochiral ketones, the corresponding α-methylene-δ-lactones were obtained as single syn-diastereoisomers. All α-methylene-δ-lactones were evaluated in vitro for their cytotoxic activity against two human leukemia cell lines, HL-60 and NALM-6, as well as the MCF-7 breast cancer cell line. One selected compound, 13h, was further tested in order to elucidate the mechanism behind its cytotoxic effect. In MCF-7 cells, this compound was shown to induce subG0/G1 cell cycle arrest, increased Bax and decreased Bcl-2 mRNA levels, and cause the dissipation of the mitochondrial membrane potential which indicated that it induced the intrinsic pathway of apoptosis.

Graphical abstract: Synthesis and anticancer properties of 3-methylene-4-(2-oxoalkyl)-3,4-dihydrocoumarins

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Feb 2016, accepted on 21 Jun 2016 and first published on 22 Jun 2016


Article type: Research Article
DOI: 10.1039/C6MD00118A
Citation: Med. Chem. Commun., 2016,7, 1745-1758

  •   Request permissions

    Synthesis and anticancer properties of 3-methylene-4-(2-oxoalkyl)-3,4-dihydrocoumarins

    D. Deredas, K. Huben, A. Janecka, A. Długosz, D. K. Pomorska, M. Mirowski, U. Krajewska, T. Janecki and H. Krawczyk, Med. Chem. Commun., 2016, 7, 1745
    DOI: 10.1039/C6MD00118A

Search articles by author

Spotlight

Advertisements